{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:45Z","timestamp":1787020485092,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key scientific research project of Traditional Chinese medicine of Wuhan Municipal Health Commission","award":["WZ22A02"],"award-info":[{"award-number":["WZ22A02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02233-1","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:38:35Z","timestamp":1763545115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early alternative splicing signatures and RBP networks in MASLD progression to cirrhosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"9","key":"2233_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2233_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/liv.14910","volume":"41","author":"A Armandi","year":"2021","unstructured":"Armandi A, Bugianesi E. Natural history of NASH. Liver Int. 2021;41:78\u201382.","journal-title":"Liver Int"},{"issue":"1","key":"2233_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-nutr-062220-105200","volume":"42","author":"L Rui","year":"2022","unstructured":"Rui L, Lin JD. Reprogramming of hepatic metabolism and microenvironment in nonalcoholic steatohepatitis. Annu Rev Nutr. 2022;42(1):91\u2013113.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"2233_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031272","volume":"22","author":"O Kwapisz","year":"2021","unstructured":"Kwapisz O, et al. Fatty acids and a high-fat diet induce epithelial\u2013mesenchymal transition by activating TGF\u03b2 and \u03b2-catenin in liver cells. Int J Mol Sci. 2021;22(3):1272.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2233_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/joim.13147","volume":"289","author":"CJ Pirola","year":"2021","unstructured":"Pirola CJ, et al. Liver mitochondrial DNA damage and genetic variability of cytochrome b\u2013a key component of the respirasome\u2013drive the severity of fatty liver disease. J Intern Med. 2021;289(1):84\u201396.","journal-title":"J Intern Med"},{"issue":"2","key":"2233_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","volume":"79","author":"N Yahoo","year":"2023","unstructured":"Yahoo N, et al. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. J Hepatol. 2023;79(2):538\u201351.","journal-title":"J Hepatol"},{"issue":"3","key":"2233_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ymthe.2021.11.010","volume":"30","author":"Q Peng","year":"2022","unstructured":"Peng Q, et al. Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics. Mol Ther. 2022;30(3):1018\u201335.","journal-title":"Mol Ther"},{"key":"2233_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-02024-3","volume":"40","author":"L Han","year":"2021","unstructured":"Han L, et al. A 5\u2032-tRNA halve, tiRNA-Gly promotes cell proliferation and migration via binding to RBM17 and inducing alternative splicing in papillary thyroid cancer. J Exp Clin Cancer Res. 2021;40:1\u201317.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"2233_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s13238-021-00856-5","volume":"13","author":"H Yang","year":"2022","unstructured":"Yang H, Beutler B, Zhang D. Emerging roles of spliceosome in cancer and immunity. Protein Cell. 2022;13(8):559\u201379.","journal-title":"Protein Cell"},{"issue":"10","key":"2233_CR10","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.cmet.2021.09.008","volume":"33","author":"Y Li","year":"2021","unstructured":"Li Y, et al. DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing. Cell Metabol. 2021;33(10):2004\u201320. e9.","journal-title":"Cell Metabol"},{"issue":"4","key":"2233_CR11","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1172\/JCI132691","volume":"130","author":"J Hyun","year":"2020","unstructured":"Hyun J, et al. Epithelial splicing regulatory protein 2\u2013mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis. J Clin Invest. 2020;130(4):2129\u201345.","journal-title":"J Clin Invest"},{"issue":"1","key":"2233_CR12","doi-asserted-by":"publisher","first-page":"31349","DOI":"10.1038\/s41598-024-82846-1","volume":"14","author":"Y Hua","year":"2024","unstructured":"Hua Y, et al. Genome-wide analysis of alternative splicing differences in hepatic ischemia reperfusion injury. Sci Rep. 2024;14(1):31349.","journal-title":"Sci Rep"},{"issue":"1","key":"2233_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12864-016-3029-z","volume":"17","author":"M-P Tremblay","year":"2016","unstructured":"Tremblay M-P, et al. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma. BMC Genomics. 2016;17(1):683.","journal-title":"BMC Genomics"},{"issue":"14","key":"2233_CR14","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.febslet.2008.03.004","volume":"582","author":"T Glisovic","year":"2008","unstructured":"Glisovic T, et al. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008;582(14):1977\u201386.","journal-title":"FEBS Lett"},{"issue":"10","key":"2233_CR15","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1172\/JCI127374","volume":"129","author":"D Kumar","year":"2019","unstructured":"Kumar D, et al. Degradation of splicing factor SRSF3 contributes to progressive liver disease. J Clin Invest. 2019;129(10):4477\u201391.","journal-title":"J Clin Invest"},{"issue":"3","key":"2233_CR16","first-page":"1271","volume":"43","author":"W Zhang","year":"2019","unstructured":"Zhang W, et al. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPAR\u03b1\/FoxO1 signaling pathway. Int J Mol Med. 2019;43(3):1271\u201380.","journal-title":"Int J Mol Med"},{"issue":"4","key":"2233_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/hep.32153","volume":"75","author":"P Subramanian","year":"2022","unstructured":"Subramanian P, et al. The RNA binding protein human antigen R is a gatekeeper of liver homeostasis. Hepatology. 2022;75(4):881\u201397.","journal-title":"Hepatology"},{"key":"2233_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)01728-7","volume":"77","author":"L Ahne","year":"2022","unstructured":"Ahne L, et al. Regulation of NEAT1 in NAFLD by RNA-binding proteins. J Hepatol. 2022;77:S705.","journal-title":"J Hepatol"},{"issue":"sup1","key":"2233_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/15476286.2021.1940037","volume":"18","author":"C Cheng","year":"2021","unstructured":"Cheng C, et al. SUVA: splicing site usage variation analysis from RNA-seq data reveals highly conserved complex splicing biomarkers in liver cancer. RNA Biol. 2021;18(sup1):157\u201371.","journal-title":"RNA Biol"},{"issue":"4","key":"2233_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041525","volume":"21","author":"T Kanda","year":"2020","unstructured":"Kanda T, et al. Molecular mechanisms: connections between nonalcoholic fatty liver disease, steatohepatitis and hepatocellular carcinoma. Int J Mol Sci. 2020;21(4):1525.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2233_CR21","doi-asserted-by":"publisher","first-page":"15455","DOI":"10.1038\/s41598-021-94671-x","volume":"11","author":"T Katopodi","year":"2021","unstructured":"Katopodi T, et al. Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3\/PTK2 immunosuppressive circuit. Sci Rep. 2021;11(1):15455.","journal-title":"Sci Rep"},{"issue":"4","key":"2233_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.livres.2022.11.001","volume":"6","author":"N Magee","year":"2022","unstructured":"Magee N, et al. Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis. Liver Res. 2022;6(4):238\u201350.","journal-title":"Liver Res"},{"issue":"4","key":"2233_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","volume":"5","author":"O Govaere","year":"2023","unstructured":"Govaere O, et al. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nat Metab. 2023;5(4):572\u20138.","journal-title":"Nat Metab"},{"issue":"3","key":"2233_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1158\/2326-6066.CIR-19-0679","volume":"9","author":"A Bernard","year":"2021","unstructured":"Bernard A, et al. The tumor microenvironment impairs Th1 IFN\u03b3 secretion through alternative splicing modifications of Irf1 pre-mRNA. Cancer Immunol Res. 2021;9(3):324\u201336.","journal-title":"Cancer Immunol Res"},{"key":"2233_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.08.007","author":"AM Jobbins","year":"2023","unstructured":"Jobbins AM, et al. Pre-RNA splicing in metabolic homeostasis and liver disease. Trends Endocrinol Metab. 2023. https:\/\/doi.org\/10.1016\/j.tem.2023.08.007.","journal-title":"Trends Endocrinol Metab"},{"issue":"15","key":"2233_CR26","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1158\/1078-0432.CCR-19-0127","volume":"25","author":"J Lin","year":"2019","unstructured":"Lin J, et al. Alterations in DNA damage repair genes in primary liver cancer. Clin Cancer Res. 2019;25(15):4701\u201311.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2233_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41379-019-0218-8","volume":"32","author":"Y Akazawa","year":"2019","unstructured":"Akazawa Y, et al. Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression. Mod Pathol. 2019;32(7):997\u20131007.","journal-title":"Mod Pathol"},{"issue":"2","key":"2233_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1840","volume":"15","author":"O Adesanya","year":"2024","unstructured":"Adesanya O, Das D, Kalsotra A. Emerging roles of RNA-binding proteins in fatty liver disease. WIREs RNA. 2024;15(2):e1840.","journal-title":"WIREs RNA"},{"key":"2233_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.984564","volume":"9","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses. Front Mol Biosci. 2022;9:984564.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2233_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12931-023-02582-4","volume":"24","author":"A Feng","year":"2023","unstructured":"Feng A, et al. Ptk2-associated gene signature could predict the prognosis of IPF. Respir Res. 2023;24(1):304.","journal-title":"Respir Res"},{"key":"2233_CR31","doi-asserted-by":"publisher","first-page":"0033","DOI":"10.34133\/research.0033","volume":"6","author":"J Tang","year":"2023","unstructured":"Tang J, et al. PTBP2-mediated alternative splicing of IRF9 controls tumor-associated monocyte\/macrophage chemotaxis and repolarization in neuroblastoma progression. Research. 2023;6:0033.","journal-title":"Research"},{"issue":"1","key":"2233_CR32","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190756","volume":"40","author":"C-M Weng","year":"2020","unstructured":"Weng C-M, et al. Bleomycin induces epithelial-to-mesenchymal transition via bFGF\/PI3K\/ESRP1 signaling in pulmonary fibrosis. Biosci Rep. 2020;40(1):BSR20190756.","journal-title":"Biosci Rep"},{"key":"2233_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108987","volume":"110","author":"Z Xu","year":"2022","unstructured":"Xu Z, et al. Igf2bp2 knockdown improves CCl4-induced liver fibrosis and TGF-\u03b2-activated mouse hepatic stellate cells by regulating Tgfbr1. Int Immunopharmacol. 2022;110:108987.","journal-title":"Int Immunopharmacol"},{"key":"2233_CR34","volume-title":"RNA-seq of human liver biopsies from patients with NAFLD, patient with cirrhosis, and healthy controls under both fasting and postprandial conditions","author":"CJNW Albrechtsen","year":"2023","unstructured":"Albrechtsen CJNW. RNA-seq of human liver biopsies from patients with NAFLD, patient with cirrhosis, and healthy controls under both fasting and postprandial conditions. Editor: BioStudies; 2023. https:\/\/www.ebi.ac.uk\/biostudies\/arrayexpress\/studies\/E-MTAB-12807."},{"issue":"8","key":"2233_CR35","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15653","volume":"11","author":"J Grandt","year":"2023","unstructured":"Grandt J, et al. Postprandial dysfunction in fatty liver disease. Physiol Rep. 2023;11(8):e15653.","journal-title":"Physiol Rep"},{"issue":"17","key":"2233_CR36","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884\u201390.","journal-title":"Bioinformatics"},{"issue":"1","key":"2233_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"5","key":"2233_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"12","key":"2233_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"6","key":"2233_CR40","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.cell.2012.04.031","volume":"149","author":"A Castello","year":"2012","unstructured":"Castello A, et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell. 2012;149(6):1393\u2013406.","journal-title":"Cell"},{"issue":"4","key":"2233_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.molcel.2016.06.029","volume":"63","author":"A Castello","year":"2016","unstructured":"Castello A, et al. Comprehensive identification of RNA-binding domains in human cells. Mol Cell. 2016;63(4):696\u2013710.","journal-title":"Mol Cell"},{"issue":"12","key":"2233_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrg3813","volume":"15","author":"S Gerstberger","year":"2014","unstructured":"Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15(12):829\u201345.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2233_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrm.2017.130","volume":"19","author":"MW Hentze","year":"2018","unstructured":"Hentze MW, et al. A brave new world of RNA-binding proteins. Nat Rev Mol Cell Biol. 2018;19(5):327\u201341.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2233_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","author":"T Wu","year":"2021","unstructured":"Wu T, et al. Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innov (Camb)"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02233-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:02:50Z","timestamp":1763550170000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02233-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02233-1","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}